At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of people living with cancer. Today, we have an industry-leading portfolio of 24 approved innovative cancer medicines and biosimilars across more than 30 indications, including breast, genitourinary, colorectal, blood and lung cancers, as well as melanoma.

More Information

• This Is Living With Cancer
• Advanced Prostate Cancer Dictionary
• African American Men’s Health
• You Deserve the Best Care
• Help Your Loved One Get the Best Care
• Caregiver Podcast Series
• Men’s Checklist
• Zero

Social Media Accounts

• Facebook
• Twitter
• Instagram

Contact Person:

Sue Hensley
susan.s.hensley@pfizer.com
(314) 503-5451